Patient monitoring equipment developer and supplier LiDCO Group has received regulatory approval for the LiDCOrapid cardiac output monitor in South Korea.
The South Korean distributor is Globaluck and it will be promoting the high usage programme. This is being offered in the US and the UK.
In the year to January 2019, revenues fell from £8.3m to £7.3m, while the loss was £2m. The loss could be halved this year.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.